Viktor von Wyl
Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies.
Daniore P, Moser A, Höglinger M, Probst-Hensch N, Imboden M, Vermes T, Keidel D, Bochud M, Ortega Herrero N, Baggio S, Chocano-Bedoya P, Rodondi N, Tancredi S, Wagner C, Cullati S, Stringhini S, Nusslé S, Veys-Takeuchi C, Zuppinger C, Harju E, Michel G, Frank I, Kahlert C, Albanese E, Crivelli L, Levati S, Amati R, Kaufmann M, Geigges M, Ballouz T, Frei A, Fehr J, von Wyl V. Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies. Int J Public Health 2023; 68:1605812.
Sep 20, 2023Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies.
Sep 20, 2023Int J Public Health 2023; 68:1605812
Daniore Paola, Moser André, Höglinger Marc, Probst-Hensch Nicole M, Imboden Medea, Vermes Thomas, Keidel Dirk, Bochud Murielle, Ortega Herrero Natalia, Baggio Stéphanie, Chocano-Bedoya Patricia O, Rodondi Nicolas, Tancredi Stefano, Wagner Cornelia, Cullati Stéphane, Stringhini Silvia, Nusslé Semira Gonseth, Veys-Takeuchi Caroline, Zuppinger Claire, Harju Erika, Michel Gisela, Frank Irène, Kahlert Christian, Albanese Emiliano, Crivelli Luca, Levati Sara, Amati Rebecca, Kaufmann Marco, Geigges Marco, Ballouz Tala, Frei Anja, Fehr Jan S, von Wyl Viktor
Changes in Healthcare Utilization During the COVID-19 Pandemic and Potential Causes-A Cohort Study From Switzerland.
Harju E, Speierer A, Jungo K, Levati S, Baggio S, Tancredi S, Noor N, Rodondi P, Cullati S, Imboden M, Keidel D, Witzig M, Frank I, Kohler P, Kahlert C, Crivelli L, Amati R, Albanese E, Kaufmann M, Frei A, von Wyl V, Puhan M, Probst-Hensch N, Michel G, Rodondi N, Chocano-Bedoya P. Changes in Healthcare Utilization During the COVID-19 Pandemic and Potential Causes-A Cohort Study From Switzerland. Int J Public Health 2023; 68:1606010.
Jul 26, 2023Changes in Healthcare Utilization During the COVID-19 Pandemic and Potential Causes-A Cohort Study From Switzerland.
Jul 26, 2023Int J Public Health 2023; 68:1606010
Harju Erika, Speierer Alexandre, Jungo Katharina Tabea, Levati Sara, Baggio Stéphanie, Tancredi Stefano, Noor Nazihah, Rodondi Pierre-Yves, Cullati Stéphane, Imboden Medea, Keidel Dirk, Witzig Melissa, Frank Irène, Kohler Philipp, Kahlert Christian, Crivelli Luca, Amati Rebecca, Albanese Emiliano, Kaufmann Marco, Frei Anja, von Wyl Viktor, Puhan Milo Alan, Probst-Hensch Nicole M, Michel Gisela, Rodondi Nicolas, Chocano-Bedoya Patricia O
Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study.
Sabatini S, Kaufmann M, Fadda M, Tancredi S, Noor N, Van Der Linden B, Cullati S, Frank I, Michel G, Harju E, Luedi C, Frei A, Ballouz T, Menges D, Fehr J, Kohler P, Kahlert C, Scheu V, Ortega N, Chocano-Bedoya P, Rodondi N, Stringhini S, Baysson H, Lorthe E, Zufferey M, Suggs L, Albanese E, Vincentini J, Bochud M, d'Acremont V, Nusslé S, Imboden M, Keidel D, Witzig M, Probst-Hensch N, von Wyl V. Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study. Int J Public Health 2023; 68:1605852.
May 22, 2023Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study.
May 22, 2023Int J Public Health 2023; 68:1605852
Sabatini Serena, Kaufmann Marco, Fadda Marta, Tancredi Stefano, Noor Nazihah, Van Der Linden Bernadette W A, Cullati Stéphane, Frank Irène, Michel Gisela, Harju Erika, Luedi Chantal, Frei Anja, Ballouz Tala, Menges Dominik, Fehr Jan S, Kohler Philipp, Kahlert Christian, Scheu Victor, Ortega Natalia, Chocano-Bedoya Patricia O, Rodondi Nicolas, Stringhini Silvia, Baysson Hélène, Lorthe Elsa, Zufferey Maria Caiata, Suggs L Suzanne, Albanese Emiliano, Vincentini Julia, Bochud Murielle, d'Acremont Valérie, Nusslé Samira Gonseth, Imboden Medea, Keidel Dirk, Witzig Melissa, Probst-Hensch Nicole M, von Wyl Viktor
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland.
Tancredi S, Ulyte A, Wagner C, Keidel D, Witzig M, Imboden M, Probst-Hensch N, Amati R, Albanese E, Levati S, Crivelli L, Kohler P, Cusini A, Kahlert C, Harju E, Michel G, Luedi C, Ortega N, Baggio S, Chocano-Bedoya P, Rodondi N, Ballouz T, Frei A, Kaufmann M, von Wyl V, Lorthe E, Baysson H, Stringhini S, Schneider V, Kaufmann L, Wieber F, Volken T, Zysset A, Dratva J, Cullati S, Corona Immunitas Research Group. Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland. Int J Equity Health 2023; 22:51.
Mar 23, 2023Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland.
Mar 23, 2023Int J Equity Health 2023; 22:51
Tancredi Stefano, Ulyte Agne, Wagner Cornelia, Keidel Dirk, Witzig Melissa, Imboden Medea, Probst-Hensch Nicole M, Amati Rebecca, Albanese Emiliano, Levati Sara, Crivelli Luca, Kohler Philipp, Cusini Alexia, Kahlert Christian, Harju Erika, Michel Gisela, Luedi Chantal, Ortega Natalia, Baggio Stéphanie, Chocano-Bedoya Patricia O, Rodondi Nicolas, Ballouz Tala, Frei Anja, Kaufmann Marco, von Wyl Viktor, Lorthe Elsa, Baysson Hélène, Stringhini Silvia, Schneider Valentine, Kaufmann Laurent, Wieber Frank, Volken Thomas, Zysset Annina, Dratva Julia, Cullati Stéphane, Corona Immunitas Research Group
The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results
Speierer A, Baysson H, Lorthe E, Pennacchio F, Frei A, Kaufmann M, Geigges M, West E, Schwab N, Cullati S, Chiolero A, Kahlert C, Stringhini S, Vollrath F, Probst-Hensch N, Rodondi N, Puhan M, Salberg É, Tall I, d'Acremont V, Chocano-Bedoya P, Anker D, Schmid A, Keidel D, Vermes T, Imboden M, Levati S, Franscella G, Corna L, Amati R, Harju E, Luedi C, Michel G, Veys-Takeuchi C, Zuppinger C, Nusslé S, von Wyl V. The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results. Int J Public Health 2022; 67:1604506.
Feb 28, 2022The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results
Feb 28, 2022Int J Public Health 2022; 67:1604506
Speierer Alexandre, Baysson Hélène, Lorthe Elsa, Pennacchio Francesco, Frei Anja, Kaufmann Marco, Geigges Marco, West Erin Ashley, Schwab Nathalie, Cullati Stéphane, Chiolero Arnaud, Kahlert Christian, Stringhini Silvia, Vollrath Fabian, Probst-Hensch Nicole, Rodondi Nicolas, Puhan Milo A, Salberg Éric, Tall Ismaël, d'Acremont Valérie, Chocano-Bedoya Patricia O, Anker Daniela, Schmid Alexia, Keidel Dirk, Vermes Thomas, Imboden Medea, Levati Sara, Franscella Giovanni, Corna Laurie, Amati Rebecca, Harju Erika, Luedi Chantal, Michel Gisela, Veys-Takeuchi Caroline, Zuppinger Claire, Nusslé Semira Gonseth, von Wyl Viktor
Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Rodgers S, Calabrese P, Ajdacic-Gross V, Steinemann N, Kaufmann M, Salmen A, Manjaly Z, Kesselring J, Kamm C, Kuhle J, Chan A, Gobbi C, Zecca C, Müller S, von Wyl V. Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?. J Psychosom Res 2021; 144:110402.
Feb 16, 2021Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Feb 16, 2021J Psychosom Res 2021; 144:110402
Rodgers Stephanie, Calabrese Pasquale, Ajdacic-Gross Vladeta, Steinemann Nina, Kaufmann Marco, Salmen Anke, Manjaly Zina-Mary, Kesselring Jürg, Kamm Christian Philipp, Kuhle Jens, Chan Andrew T, Gobbi Claudio, Zecca Chiara, Müller Stefanie, von Wyl Viktor
60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments.
Kaufmann M, Puhan M, Salmen A, Kamm C, Manjaly Z, Calabrese P, Schippling S, Müller S, Kuhle J, Pot C, Gobbi C, Steinemann N, von Wyl V, Swiss Multiple Sclerosis Registry (SMSR). 60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments. Front Neurol 2020; 11:156.
Mar 6, 202060/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments.
Mar 6, 2020Front Neurol 2020; 11:156
Kaufmann Marco, Puhan Milo Alan, Salmen Anke, Kamm Christian Philipp, Manjaly Zina-Mary, Calabrese Pasquale, Schippling Sven, Müller Stefanie, Kuhle Jens, Pot Caroline, Gobbi Claudio, Steinemann Nina, von Wyl Viktor, Swiss Multiple Sclerosis Registry (SMSR)
How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.
Barin L, Kamm C, Salmen A, Dressel H, Calabrese P, Pot C, Schippling S, Gobbi C, Müller S, Chan A, Rodgers S, Kaufmann M, Ajdacic-Gross V, Steinemann N, Kesselring J, Puhan M, von Wyl V, Swiss Multiple Sclerosis Registry. How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis. Mult Scler 2019; 26:489-500.
Jan 18, 2019How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.
Jan 18, 2019Mult Scler 2019; 26:489-500
Barin Laura, Kamm Christian Philipp, Salmen Anke, Dressel Holger, Calabrese Pasquale, Pot Caroline, Schippling Sven, Gobbi Claudio, Müller Stefanie, Chan Andrew T, Rodgers Stephanie, Kaufmann Marco, Ajdacic-Gross Vladeta, Steinemann Nina, Kesselring Jürg, Puhan Milo Alan, von Wyl Viktor, Swiss Multiple Sclerosis Registry
A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity.
Puhan M, Steinemann N, Kamm C, Müller S, Kuhle J, Kurmann R, Calabrese P, Kesselring J, von Wyl V, Swiss Multiple Sclerosis Registry Smsr. A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity. Swiss Med Wkly 2018; 148:w14623.
May 16, 2018A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity.
May 16, 2018Swiss Med Wkly 2018; 148:w14623
Puhan Milo Alan, Steinemann Nina, Kamm Christian Philipp, Müller Stefanie, Kuhle Jens, Kurmann Roland, Calabrese Pasquale, Kesselring Jürg, von Wyl Viktor, Swiss Multiple Sclerosis Registry Smsr
Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis
Scherrer A, Günthard H, Bernasconi E, Vernazza P, Calmy A, Furrer H, Battegay M, Cavassini M, Aubert V, Klimkait T, Yerly S, Böni J, Kouyos R, Yang W, von Wyl V. Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis. Clin Infect Dis 2016
Mar 8, 2016Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis
Mar 8, 2016Clin Infect Dis 2016
Scherrer Alexandra U, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Calmy Alexandra, Furrer Hansjakob, Battegay Manuel, Cavassini Matthias, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Kouyos Roger, Yang Wan-Lin, von Wyl Viktor
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Metzner K, Günthard H, Weber R, Bernasconi E, Calmy A, Cavassini M, Vernazza P, Hirsch H, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, von Wyl V, Scherrer A, the Swiss HIV Cohort Study. Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS 2014; 28:2231-2239.
Sep 24, 2014Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Sep 24, 2014AIDS 2014; 28:2231-2239
Metzner Karin J, Günthard Huldrych F, Weber Rainer, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Hirsch Hans H, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Scherrer Alexandra U, the Swiss HIV Cohort Study
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
Drescher S, Kouyos R, Günthard H, Ledergerber B, Vernazza P, Bernasconi E, Cavassini M, Ambrosioni J, Battegay M, Furrer H, Taffé P, Klimkait T, Aubert V, Shah C, Yerly S, Böni J, Yang W, von Wyl V, Swiss HIV Cohort Study. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. Clin Infect Dis 2013; 58:285-94.
Oct 21, 2013Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
Oct 21, 2013Clin Infect Dis 2013; 58:285-94
Drescher Sara M, Kouyos Roger D, Günthard Huldrych F, Ledergerber Bruno, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Ambrosioni Juan, Battegay Manuel, Furrer Hansjakob, Taffé Patrick, Klimkait Thomas, Aubert Vincent, Shah Cyril, Yerly Sabine, Böni Jürg, Yang Wan-Lin, von Wyl Viktor, Swiss HIV Cohort Study
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
von Wyl V, Glass T, Bucher H, Günthard H, Aubert V, Böni J, Bernasconi E, Calmy A, Cavassini M, Furrer H, Nicca D, Yerly S, Klimkait T, Swiss HIV Cohort Study. Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study. PloS one 2013; 8:e77691.
Oct 16, 2013Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
Oct 16, 2013PloS one 2013; 8:e77691
von Wyl Viktor, Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Aubert Vincent, Böni Jürg, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Furrer Hansjakob, Nicca Dunja, Yerly Sabine, Klimkait Thomas, Swiss HIV Cohort Study
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients
Beerenwinkel N, Günthard H, Cellerai C, Klimkait T, Böni J, Yerly S, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Battegay M, Furrer H, von Wyl V, Knupfer P, Schuhmacher H, Montazeri H, Swiss HIV Cohort Study. The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients. PLoS Comput Biol 2013; 9:e1003203.
Aug 29, 2013The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients
Aug 29, 2013PLoS Comput Biol 2013; 9:e1003203
Beerenwinkel Niko, Günthard Huldrych F, Cellerai Cristina, Klimkait Thomas, Böni Jürg, Yerly Sabine, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Battegay Manuel, Furrer Hansjakob, von Wyl Viktor, Knupfer Patrick, Schuhmacher Heike, Montazeri Hesam, Swiss HIV Cohort Study
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Metzner K, Aubert V, Furrer H, Battegay M, Vernazza P, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard H, Klimkait T, Yerly S, Böni J, Scherrer A, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Swiss HIV Cohort Study. Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. J Infect Dis 2013; 208:1102-12.
Jul 11, 2013Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Jul 11, 2013J Infect Dis 2013; 208:1102-12
Metzner Karin J, Aubert Vincent, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Weber Rainer, Günthard Huldrych F, Klimkait Thomas, Yerly Sabine, Böni Jürg, Scherrer Alexandra U, Preiswerk Benjamin, Joos Beda, von Wyl Viktor, Leemann Christine, Rieder Philip, Braun Dominique, Grube Christina, Kuster Herbert, Swiss HIV Cohort Study
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Scherrer A, Günthard H, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Cellerai C, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PloS one 2012; 7:e37983.
Jun 18, 2012Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Jun 18, 2012PloS one 2012; 7:e37983
Scherrer Alexandra U, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Cellerai Cristina, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
von Wyl V, Günthard H, Joos B, Weber R, Vernazza P, Hirschel B, Rauch A, Cavassini M, Bernasconi E, Battegay M, Kuster H, Niederoest B, Fischer M, Gianella S, the Swiss HIV Cohort Study (SHCS). Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption. PloS one 2011; 6:e27463.
Nov 15, 2011Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
Nov 15, 2011PloS one 2011; 6:e27463
von Wyl Viktor, Günthard Huldrych F, Joos Beda, Weber Rainer, Vernazza Pietro, Hirschel Bernard, Rauch Andri, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Kuster Herbert, Niederoest Barbara, Fischer Marek, Gianella Sara, the Swiss HIV Cohort Study (SHCS)
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
von Wyl V, Günthard H, Ledergerber B, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Cellerai C, Shah C, Böni J, Yerly S, Swiss HIV Cohort Study. Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clin Infect Dis 2011; 54:131-40.
Nov 4, 2011Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
Nov 4, 2011Clin Infect Dis 2011; 54:131-40
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Cellerai Cristina, Shah Cyril, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Scherrer A, Günthard H, Held L, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Hirschel B, Rauch A, Bürgisser P, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis 2011; 53:1143-52.
Oct 13, 2011Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Oct 13, 2011Clin Infect Dis 2011; 53:1143-52
Scherrer Alexandra U, Günthard Huldrych F, Held Leonhard, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Rauch Andri, Bürgisser Philippe, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
von Wyl V, Günthard H, Bonhoeffer S, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Staehelin C, Cavassini M, Hirschel B, Weber R, Klimkait T, Bürgisser P, Shah C, Böni J, Yerly S, Kouyos R, Swiss HIV Cohort Study. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 2011; 204:1095-103.
Oct 1, 2011The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
Oct 1, 2011J Infect Dis 2011; 204:1095-103
von Wyl Viktor, Günthard Huldrych F, Bonhoeffer Sebastian, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Staehelin Cornelia, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Klimkait Thomas, Bürgisser Philippe, Shah Cyril, Böni Jürg, Yerly Sabine, Kouyos Roger D, Swiss HIV Cohort Study